INSITE VISION INCORPORATED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 11244
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 1139

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9044508 Concentrated aqueous azalide formulationsMar 15, 13Jun 02, 15[A61K]
7795231 Concentrated aqueous azalide formulationsOct 04, 07Sep 14, 10[A61K]
7749970 Topical treatment of prevention of ocular infectionsApr 07, 03Jul 06, 10[A61K]
7732415 Topical treatment or prevention of ocular infectionsJul 26, 04Jun 08, 10[A61K]
7056893 Topical treatment for prevention of ocular infectionsJun 04, 02Jun 06, 06[A61K]
6569443 Topical treatment or prevention of ocular infectionsJan 24, 01May 27, 03[A61K, A61F]
6239113 Topical treatment or prevention of ocular infectionsJul 02, 99May 29, 01[A61K]
6159458 Sustained release ophthalmic compositions containing water soluble medicamentsNov 04, 97Dec 12, 00[A61K]
5814655 Non-steroidal ophthalmic mixturesNov 14, 96Sep 29, 98[A61K]
5332582 Stabilization of aminosteroids for topical ophthalmic and other applicationsDec 02, 92Jul 26, 94[A61K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0128,481 OCULAR TREATMENT WITH REDUCED INTRAOCULAR PRESSUREAbandonedJul 09, 15May 11, 17[A61K]
2013/0217,657 COMBINATION ANTI-INFLAMMATORY OPHTHALMIC COMPOSITIONSAbandonedMar 25, 13Aug 22, 13[A61K]
2013/0165,419 COMBINATION ANTI-INFLAMMATORY OPHTHALMIC COMPOSITIONSAbandonedDec 21, 11Jun 27, 13[A61K, A61P]
2010/0305,054 CONCENTRATED AQUEOUS AZALIDE FORMULATIONSAbandonedAug 12, 10Dec 02, 10[A61K, A61P]
2008/0103,103 Reagents and methods to treat ocular diseases and infectionAbandonedOct 30, 06May 01, 08[A61K]
2006/0046,970 Topical otic compositions and methods of topical treatment of prevention of otic infectionsAbandonedAug 31, 04Mar 02, 06[A61K]
2005/0255,506 NOS-2 and glaucomaAbandonedFeb 16, 05Nov 17, 05[C12Q]
2003/0190,617 Optineurin nucleic acid molecules and uses thereofAbandonedMar 06, 02Oct 09, 03[C07H, C12Q, C12N]
2003/0119,000 Methods to screen and treat individuals with glaucoma or the propensity to develop glaucomaAbandonedNov 05, 01Jun 26, 03[A61K, C12Q, C12P]
6372245 Plasticized bioerodible controlled delivery systemExpiredApr 22, 94Apr 16, 02[A61K]
2001/0029,269 Ophthalmic compositionsAbandonedMay 24, 01Oct 11, 01[A61K]
2001/0008,961 Injection apparatus and method of using sameAbandonedFeb 14, 01Jul 19, 01[A61M]
5977171 Sustained release emulsionsExpiredNov 26, 97Nov 02, 99[A61K]
5767153 Sustained release emulsionsExpiredJun 07, 95Jun 16, 98[A61K]
5538721 Stabilization of aminosteroids for topical ophthalmic and other applicationsExpiredFeb 28, 94Jul 23, 96[A61K]
5474764 Alkaline ophthalmic suspensionsExpiredMay 24, 94Dec 12, 95[A61K]
5340572 Alkaline ophthalmic suspensionsExpiredFeb 08, 93Aug 23, 94[A61K, A61F]
5256408 Aminosteroids for ophthalmic useExpiredFeb 19, 92Oct 26, 93[A61K]
5252319 Aminosteroids for ophthalmic useExpiredFeb 19, 92Oct 12, 93[A61K]
5209926 Aminosteroids for ophthalmic useExpiredAug 24, 92May 11, 93[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.